美國居民不適用 XM 服務。

Europe's STOXX 600 edges up in global recovery, earnings relief



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>UPDATE 2-Europe's STOXX 600 edges up in global recovery, earnings relief</title></head><body>

For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window

German industrial orders swell in ray of hope for weak economy

Novo Nordisk logs biggest one-day gain in five months

Bayer shares drop after earnings hit by tough farm market

Monte dei Paschi di Siena up after raising profit outlook

STOXX 600 up 0.3%

Updated at 1600 GMT

By Pranav Kashyap and Ankika Biswas

Aug 6 (Reuters) -European shares rose on Tuesday, mirroring a recovery in global markets after the previous day's mauling, with energy and technology stocks leading the way as a slew of upbeat corporate earnings also lifted sentiment.

The STOXX 600 .STOXX closed 0.3% higher, after logging its steepest three-day decline since June 2022 and closing below the key 500-point mark for a second day on Monday on U.S. recession fears.

The "fear gauge" Euro STOXX volatility index .V2TX also cooled down from its highest level since March 2022 hit on Monday, reflecting an improved investor mood.

Wall Street climbed in volatile trading, as investors looked for bargain hunting, while dovish commentary from Federal Reserve officials also lifted the mood.

Among others, Japan's Nikkei .N225 closed up 10% after its biggest daily sell-off since the 1987 Black Monday crash.

Investor nerves appeared to be soothed after Fed policymakers pushed back against recession concerns, but also warned that the central bank will need to cut rates to avoid such an outcome.

However, Tuesday's market recovery was contained as traders refrained from making big bets, reassessing the impact of the pullback and awaiting fresh bullish catalysts.

Main indexes in Germany .GDAXI, France .FCHI and Spain .IBEX ended the session marginally high to 0.3% down.

Furthermore, data reflected a stronger-than-expected rise in German industrial orders, providing some hope for Europe's largest economy, where recession is back on the cards following a contraction in second quarter.

"The euro zone data do not scream 'rate cut' – the economy is growing at a steady pace and domestic inflation has stabilised at a high level," said Jack Allen-Reynolds, Capital Economics' deputy chief euro zone economist.

"But we suspect most ECB policymakers will judge a cut is justified next month, and recent concerns about the U.S. strengthen their case."

Technology .SX8P was the top sectoral gainer, up 1.7%, led by semiconductor stocks such as ASM International ASMI.AS, ASML ASML.AS and BE Semiconductor BESI.AS.

Heavyweight Novo Nordisk NOVOb.CO also rebounded with a 4.6% jump, its biggest one-day gain in nearly five months, ahead of the drugmaker's quarterly results on Wednesday.

Italian bank Monte dei Paschi di Siena BMPS.MI jumped 9% after raising its profit outlook and dividend payout goal through 2028.

Switzerland's Sonova SOON.S rose 6% after introducing a hearing aid that utilises real-time AI to improve speech clarity from background noise.

Industrial kitchen retailer Rational AG RAAG.DE jumped 7.2% after its results.

Meanwhile, Bayer BAYGn.DE slumped 6% after following weak quarterly adjusted earnings, while Swiss healthcare company Galenica GALE.S fell 4% after "underwhelming" first-half results.



Reporting by Pranav Kashyap and Ankika Biswas in Bengaluru; Editing by Sherry Jacob-Phillips, Varun H K and David Evans

</body></html>

免責聲明: XM Group提供線上交易平台的登入和執行服務,允許個人查看和/或使用網站所提供的內容,但不進行任何更改或擴展其服務和訪問權限,並受以下條款與條例約束:(i)條款與條例;(ii)風險提示;(iii)完全免責聲明。網站內部所提供的所有資訊,僅限於一般資訊用途。請注意,我們所有的線上交易平台內容並不構成,也不被視為進入金融市場交易的邀約或邀請 。金融市場交易會對您的投資帶來重大風險。

所有缐上交易平台所發佈的資料,僅適用於教育/資訊類用途,不包含也不應被視爲適用於金融、投資稅或交易相關諮詢和建議,或是交易價格紀錄,或是任何金融商品或非應邀途徑的金融相關優惠的交易邀約或邀請。

本網站的所有XM和第三方所提供的内容,包括意見、新聞、研究、分析、價格其他資訊和第三方網站鏈接,皆爲‘按原狀’,並作爲一般市場評論所提供,而非投資建議。請理解和接受,所有被歸類為投資研究範圍的相關内容,並非爲了促進投資研究獨立性,而根據法律要求所編寫,而是被視爲符合營銷傳播相關法律與法規所編寫的内容。請確保您已詳讀並完全理解我們的非獨立投資研究提示和風險提示資訊,相關詳情請點擊 這裡查看。

風險提示:您的資金存在風險。槓桿商品並不適合所有客戶。請詳細閱讀我們的風險聲明